ClinicalTrials.Veeva

Menu

Improving Lactation Success in Mothers of Critically Infants

University of Florida logo

University of Florida

Status

Active, not recruiting

Conditions

Breast Pumping

Treatments

Behavioral: Text message including biomarker of breast pumping adequacy

Study type

Interventional

Funder types

Other

Identifiers

NCT04097860
IRB201902053

Details and patient eligibility

About

The purpose of this study is to determine the feasibility and potential benefits of a mHealth intervention to increase BM pumping frequency and BM production in mothers delivering critically ill infants admitted to the neonatal intensive care unit

Full description

Although compelling evidence exists that breast milk (BM) improves infant health, mothers of critically ill infants frequently produce insufficient amounts BM which is likely due to inadequate daily breast pumping frequency. BM sodium levels are an easy to measure biomarker of pumping frequency and providing this information to mothers via text messaging may increase their pumping frequency and BM production. Therefore, the overall objective of this pilot study is to determine the feasibility and potential benefits of a mHealth intervention to increase BM pumping frequency and BM production in mothers delivering critically ill infants admitted to the neonatal intensive care unit (NICU) at University of Florida Health. Specific aims include (1) evaluate the feasibility of a mHealth intervention to increase BM pumping frequency and BM production and (2) assess whether results indicate a signal of effectiveness supporting a subsequent adequately powered randomized clinical trial (RCT). Following delivery, 50 mothers of critically ill infants admitted to the NICU will be randomized to one of two groups. The Enhanced Intervention Group will receive text messages including both general lactation information and a personalized message consisting of the mother's BM sodium level, pumping frequency and feedback regarding pumping frequency. The Standard Intervention Group will receive only general lactation information. Results will be used to revise the intervention and study processes and to estimate outcome measurement variability and effect sizes needed for sample size calculations for an adequately powered RCT.

Enrollment

122 patients

Sex

Female

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • stated intent to provide BM to the infant
  • infant not expected to be stable enough to bottle/breastfeed for > 14 days
  • owns a mobile phone with unrestricted SMS capability.
  • English speaking

Exclusion criteria

  • known illicit drug use
  • breast reduction or augmentation
  • positive HIV status
  • does not anticipate being able to bring BM to the NICU at least 4X/week
  • infant not expected to live > 7 days following delivery
  • COVID-19 positive

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

122 participants in 2 patient groups

Intervention group
Experimental group
Description:
Will be sent one message that includes general information pertinent to all mothers expressing BM for their infants and one personalized real-time biomarker based message which will include the sodium level contained in the BM since the previous message, the number of times pumped on those days and will either congratulate the participant on how well the is pumping BM for the infant or how many more times per day the participant needs to pump to decrease the BM sodium level and increase BM production
Treatment:
Behavioral: Text message including biomarker of breast pumping adequacy
Control group
No Intervention group
Description:
Will only be sent text messages that include the same general lactation information sent to the treatment group

Trial contacts and locations

1

Loading...

Central trial contact

Leslie A Parker, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems